Literature DB >> 843682

The specificity of oestrogen receptor in brain, pituitary and uterus.

M Ginsburg, N J Maclusky, I D Morris, P J Thomas.   

Abstract

1 The specificity of oestrogen receptor in rat brain regions (hypothalamus, amygdala and cortex), pituitary and uterus was studied by measurement of the inhibition of 17beta-oestradiol high affinity binding in cytosol, in the presence of unlabelled putative inhibitors of binding. 2 Binding was inhibited only by those of the compounds tested that possessed oestrogen agonist or antagonist activity. The affinities were estimated and the ranking order of the compounds was the same in all tissue sources of cytosol and corresponded to the ranking order of agonist or antagonist potency. 3 There were some significant differences between some of the estimated affinities in different tissues, these being seen most commonly between pituitary and hypothalamus on one hand and uterus on the other. 4 The possibility of heterogeneity of oestrogen receptor is discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 843682      PMCID: PMC1667961          DOI: 10.1111/j.1476-5381.1977.tb08392.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  An improved method for the study of high-affinity steroid binding:-oestradiol binding in brain and pituitary.

Authors:  M Ginsburg; B D Greenstein; N J MacLusky; I D Morris; P J Thomas
Journal:  Steroids       Date:  1974-06       Impact factor: 2.668

2.  The uptake and metabolism of (1,2- 3 H)-testosterone by the brain of functionally hepatectomized and totally eviscerated male rats.

Authors:  L J Sholiton; C E Jones; E E Werk
Journal:  Steroids       Date:  1972-10       Impact factor: 2.668

3.  The mechanism of oestradiol binding in rat hypothalamus: effect of androgenization.

Authors:  M Vértes; R J King
Journal:  J Endocrinol       Date:  1971-10       Impact factor: 4.286

4.  Competition of phenothiazines with oestradiol for oestradiol receptors in rat brain.

Authors:  J Shani; Y Givant; F G Sulman; U Eylath; B Eckstein
Journal:  Neuroendocrinology       Date:  1971       Impact factor: 4.914

5.  Oestradiol binding in hypothalamic cytosol.

Authors:  M Ginsburg; N J Maclusky; I D Morris; P J Thomas
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

6.  Radio-ligand binding assay of specific estrogens using a soluble uterine macromolecule.

Authors:  S G Korenman
Journal:  J Clin Endocrinol Metab       Date:  1968-01       Impact factor: 5.958

7.  Estradiol "receptors" in hypothalamus and anterior pituitary gland: inhibition of estradiol binding by SH-group blocking agents and clomiphene citrate.

Authors:  I Kahwanago; W L Heinrichs; W L Herrmann
Journal:  Endocrinology       Date:  1970-06       Impact factor: 4.736

8.  Peripheral plasma oestradiol and luteinizing hormone concentrations during the oestrous cycle of the rat.

Authors:  K Brown-Grant; D Exley; F Naftolin
Journal:  J Endocrinol       Date:  1970-10       Impact factor: 4.286

9.  The binding affinity and specificity of the estrogen receptor of the rat uterus and anterior pituitary.

Authors:  A C Notides
Journal:  Endocrinology       Date:  1970-11       Impact factor: 4.736

10.  Influence of rat estradiol binding plasma protein (EBP) on uterotrophic activity.

Authors:  J P Raynaud
Journal:  Steroids       Date:  1973-02       Impact factor: 2.668

View more
  4 in total

1.  Estrogen-induced activation of the mitogen-activated protein kinase cascade in the cerebral cortex of estrogen receptor-alpha knock-out mice.

Authors:  M Singh; G Sétáló; X Guan; D E Frail; C D Toran-Allerand
Journal:  J Neurosci       Date:  2000-03-01       Impact factor: 6.167

2.  Differential depletion of cytoplasmic high affinity oestrogen receptors after the in vivo administration of the antioestrogens, clomiphene, MER-25 and tamoxifen.

Authors:  R N Kurl; I D Morris
Journal:  Br J Pharmacol       Date:  1978-04       Impact factor: 8.739

3.  Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain. Evidence for selective increases of glucocorticoid receptor immunoreactivity in the locus coeruleus and in 5-hydroxytryptamine nerve cell groups of the rostral ventromedial medulla.

Authors:  I Kitayama; A M Janson; A Cintra; K Fuxe; L F Agnati; S O Ogren; A Härfstrand; P Eneroth; J A Gustafsson
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

Review 4.  Role of Thioredoxin-Interacting Protein in Diseases and Its Therapeutic Outlook.

Authors:  Naila Qayyum; Muhammad Haseeb; Moon Suk Kim; Sangdun Choi
Journal:  Int J Mol Sci       Date:  2021-03-09       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.